HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis.

AbstractBACKGROUND:
Sarcopenia has become a serious disorder in modern society. Chronic kidney disease requiring dialysis and diabetes are some of the disorders that accelerate the onset and progression of sarcopenia. We, therefore, investigated the prevalence of sarcopenia in patients undergoing hemodialysis (HD) and confirmed the impact of diabetes mellitus (DM) on this population.
METHODS:
This study included 308 patients whose muscle strength and mass had been evaluated using handgrip strength and dual-energy X-ray absorptiometry, respectively. Sarcopenia was defined according to the criteria established by the Asian Working Group on Sarcopenia. In addition, this cohort had been followed up for 9 years.
RESULTS:
The prevalence of sarcopenia was 40% (37% in males and 45% in females) with gender differences being insignificant (p = 0.237). The DM morbidity rate was significantly higher in those with sarcopenia than in those without sarcopenia (41% vs. 27%, p = 0.015). Multivariate regression analyses showed that the presence of DM was an independent contributor to sarcopenia in patients undergoing HD (odds ratio 3.11; 95% confidence interval 1.63-5.93; p <  0.001). During the follow-up of 76 ± 35 months, 100 patients died. Patients with sarcopenia demonstrated significantly higher rates of all-cause mortality than those without sarcopenia (p <  0.001 using the log-rank test). Multivariate Cox proportional hazards analyses revealed that the presence of DM was significantly associated with higher all-cause mortality (adjusted hazard ratio: 2.39; 95% confidence interval 1.51-3.81; p <  0.001).
CONCLUSIONS:
The prevalence of sarcopenia among this cohort of patients undergoing HD was determined to be 40%. Moreover, the presence of DM was an independent contributor to sarcopenia and an independent predictor of all-cause mortality in this population.
AuthorsKatsuhito Mori, Kozo Nishide, Senji Okuno, Tetsuo Shoji, Masanori Emoto, Akihiro Tsuda, Shinya Nakatani, Yasuo Imanishi, Eiji Ishimura, Tomoyuki Yamakawa, Shigeichi Shoji, Masaaki Inaba
JournalBMC nephrology (BMC Nephrol) Vol. 20 Issue 1 Pg. 105 (03 28 2019) ISSN: 1471-2369 [Electronic] England
PMID30922266 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Cohort Studies
  • Diabetes Mellitus (diagnosis, mortality)
  • Female
  • Follow-Up Studies
  • Hand Strength (physiology)
  • Humans
  • Male
  • Middle Aged
  • Mortality (trends)
  • Muscle Strength (physiology)
  • Renal Dialysis (adverse effects, trends)
  • Renal Insufficiency, Chronic (diagnosis, mortality, therapy)
  • Sarcopenia (diagnosis, mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: